Abstract
Ocular adnexal tumors are relatively rare but require unique diagnostic and treatment considerations given the functional importance of the eye and periocular structures and their unique metastatic behavior. In the following paper, we review the major malignant tumors of the ocular adnexa including the eyelid, conjunctiva and orbit. Frozen section control of the margins and, in selected cases, Mohs microsurgery have decreased the recurrence rate in malignant eyelid tumors. Intraoperative cryotherapy and postoperative topical mitomycin C have similarly contributed to better surgical outcomes in conjunctival malignant tumors including squamous cell carcinoma and malignant melanoma. Immunotherapy with CD20 antibodies is a developing treatment in ocular adnexal lymphomas.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 63-75 |
| Number of pages | 13 |
| Journal | Expert Review of Ophthalmology |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 2008 |
Keywords
- Burkitt's lymphoma
- Conjunctival primary and acquired melanosis and melanoma
- Kaposi's sarcoma
- Lymphoid tumor
- Metastatic eyelid tumor
- Metastatic orbital tumor
- Secondary orbital tumor
ASJC Scopus subject areas
- Biomedical Engineering
- Ophthalmology
- Optometry